Sivextro

(Tedizolid phosphate)

Sivextro

Drug updated on 11/13/2023

Dosage FormInjection (intravenous: 200 mg); Tablet (oral: 200 mg)
Drug ClassOxazolidinone antibacterials
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria.